New pharmacological agents under clinical investigation for treating disorders of lipoprotein regulation leading to atherosclerosis

Author： Gallup E.   Dujovne C.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.3, 2001-03, pp. : 561-567

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological and Clinical Studies on Purine Nucleoside Analogs- New Anticancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 5, 2006-05 ,pp. : 575-581

Bentham Science Publishers

Access to resources Recommend Favorite

Nanocrystals, a New Tool to Study Lipoprotein Metabolism and Atherosclerosis

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 2, 2012-02 ,pp. : 365-372

Bentham Science Publishers

Access to resources Recommend Favorite

Berberine: New Insights from Pharmacological Aspects to Clinical Evidences in the Management of Metabolic Disorders

By  

Current Medicinal Chemistry, Vol. 23, Iss. 14, 2016-04 ,pp. : 1460-1476

Bentham Science Publishers

Access to resources Recommend Favorite

Novel pharmacological agents in clinical development for solid tumours

By Dy Grace K   Haluska Paul   Adjei Alex A  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 12, 2001-12 ,pp. : 2059-2088

Informa Healthcare

Access to resources Recommend Favorite

Inflammatory Disorders and Atherosclerosis: New Therapeutic Approaches

By  

Current Pharmaceutical Design, Vol. 17, Iss. 37, 2011-12 ,pp. : 4111-4120

Bentham Science Publishers

Access to resources Recommend Favorite